MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
common stock and...
$5,409,673
Proceeds from issuance of
common stock and...
$4,080,000
Proceeds from issuance of
pre-funded warrants, net of...
$2,264,485
Proceeds from exercise of
pre-funded warrants
$20,151
Net change in cash
and cash...
-$1,586,139
Net cash provided by
(used in) financing...
$10,952,228
Canceled cashflow
$822,081
Net change in cash
and cash...
-$1,586,139
Canceled cashflow
$10,952,228
Stock-based compensation
$932,967
Accounts payable and
accrued expenses
$422,994
Gain on settlement of
debt
-$342,650
Depreciation and
amortization
$290,107
Prepaid expenses
-$121,867
Impairment of right-of-use
asset
$109,235
Change in fair value of
derivative liabilities
-$74,406
Amortization of debt discount
and finance fees
$62,030
Change in fair value of
convertible notes
-$3,351
Payment of other
issuance costs for...
$557,659
Repayment of note
payable-related party
$190,270
Payment for finance
costs
$74,152
Net cash used in
operating activities
-$9,481,645
Canceled cashflow
$2,359,607
Net cash (used in)
provided by investing...
-$3,056,722
Net loss
-$11,721,669
Interest payments on
convertible notes accounted...
-$115,339
Change in operating
lease asset and...
-$2,459
Accrued interest
payable - related...
-$1,785
Investment in developed
technology related to...
$3,044,722
Payments made for
capitalized software
$12,000
Back
Back
Cash Flow
source: myfinsight.com
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)